About 223 results

ALLMedicine™ Parathyroid Hormone-related Peptide Center

Research & Reviews  84 results

Recurrent distal cholangiocarcinoma and humoral hypercalcemia of malignancy: report of ...
Endocrine Journal; Ito J, Sakai K et. al.

Dec 22nd, 2022 - A 61-year-old Japanese woman presented with epigastric pain and jaundice. Imaging showed the presence of primary distal cholangiocarcinoma (DCC). A subtotal stomach-preserving pancreaticoduodenectomy was performed, followed by chemotherapy using S...

Hormonal regulation of mammary gland development and lactation.
Nature Reviews. Endocrinology; Hannan FM, Elajnaf T et. al.

Oct 4th, 2022 - Lactation is critical to infant short-term and long-term health and protects mothers from breast cancer, ovarian cancer and type 2 diabetes mellitus. The mammary gland is a dynamic organ, regulated by the coordinated actions of reproductive and me...

Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells i...
World Journal of Gastroenterology; Novoa Díaz MB, Carriere P et. al.

Sep 3rd, 2022 - Parathyroid hormone-related peptide (PTHrP) plays a key role in the development and progression of many tumors. We found that in colorectal cancer (CRC) HCT116 cells, the binding of PTHrP to its receptor PTHR type 1 (PTHR1) activates events associ...

Abaloparatide Enhances Fusion and Bone Formation in a Rabbit Spinal Arthrodesis Model.
Spine Morse KW, Moore H et. al.

Aug 10th, 2022 - Prospective randomized placebo controlled animal trial. Determine the effect of daily subcutaneous abaloparatide injection on the intervertebral fusion rate in rabbits undergoing posterolateral fusion. Despite the wide utilization of spine fusion,...

A Case of a Rare Parathyroid Hormone (PTH)-Producing Neuroendocrine Tumor.
The American Journal of Case Reports; Quinn CD, Chaudhary F et. al.

Jul 19th, 2022 - BACKGROUND Neuroendocrine neoplasms are commonly seen in association with hormone production, and clinical signs that arise from these hormonal effects often manifest as the first presentation of malignancy. The excess production of parathyroid ho...

see more →

Clinicaltrials.gov  1 results

Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)

Apr 24th, 2014 - Bone metastases are frequently one of the first signs of disseminated disease in cancer patients. Skeletal complications due to metastatic disease include (severe) bone pain, spinal cord compromise, pathological fractures, and hypercalcemia. Zoled...

see more →

News  4 results

More Drug Shortages; Intermittent Fasting for T2D; Obesity Tri-Agonist in Phase III

Dec 20th, 2022 - The FDA added Eli Lilly's tirzepatide (Mounjaro) and dulaglutide (Trulicity) to its shortage list this week. (Reuters) The decision to go ahead with bariatric surgery was closely tied with patient satisfaction in their patient-physician relationsh...

Recognizing the Symptoms of NETs

Apr 2nd, 2021 - Transcript: Simron Singh, MD: So Jon, we talked a bit about the patients who present with functional NETs [neuroendocrine tumors] or symptoms. What are some of the hormones that cause the symptoms you see in patients with neuroendocrine cancer...

Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis

Abstract and Introduction Abstract Context: Abaloparatide is a US Food and Drug Administration-approved parathyroid hormone-related peptide analog for treatment of osteoporosis in postmenopausal women at high risk of fracture. Objectives: We asses...

Mechanisms of Cancer Cell Metastasis to the Bone

Types of Bone Metastatic Tumors Leo Tolstoy began his 1873 work; 'Anna Karenina', with the line, "Happy families are all alike; every unhappy family is unhappy in its own way".[52] While the subject of Tolstoy's work is vastly different from that ...

see more →